Home/Filings/4/0001104659-18-000925
4//SEC Filing

Cavan John T 4

Accession 0001104659-18-000925

CIK 0001583771other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 1:09 PM ET

Size

4.8 KB

Accession

0001104659-18-000925

Insider Transaction Report

Form 4
Period: 2018-01-03
Cavan John T
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-01-03+101,221167,947 total
Footnotes (1)
  • [F1]The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.

Documents

1 file

Issuer

ContraVir Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1
  • filerCIK 0001503738

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 1:09 PM ET
Size
4.8 KB